Did not become law. It stopped in the House of Representatives's Public Health Committee on March 9, 2001. The 2001 session has ended.
2001 Regular Session
House Bill 6076
AN ACT CONCERNING THE REPORTING OF PHARMACEUTICAL ADVERTISING AND PROMOTIONAL COSTS.
What it does
The synopsis the General Assembly published with the bill.
To determine the impact of pharmaceutical company advertising and promotional costs on the price of prescription drugs and on practice patterns in Connecticut.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
Its course
January 17 to March 9, 2001, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action3 actions on 3 days
In the House of RepresentativesJan 17 to Mar 9 · stopped51 days
Public Health CommitteeJan 17 to Mar 9 · stopped51 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the House of Representatives Jan 17 – Mar 9
- Jan 17Introduced and sent to Public Health Committee
- Mar 9Heard in Public Health Committee
All 3 actions, as published
- Jan 17REF. TO JOINT COMM. ONBoth houses
- Feb 1Reserved for Subject Matter Public HearingBoth houses
- Mar 9PUBLIC HEARINGBoth houses